相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Preparation and evaluation of tacrolimus-loaded nanoparticles for lymphatic delivery
Sae-Byeok Shin et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2010)
Vitamin E TPGS P-Glycoprotein Inhibition Mechanism: Influence on Conformational Flexibility, Intracellular ATP Levels, and Role of Time and Site of Access
Eva-Maria Collnot et al.
MOLECULAR PHARMACEUTICS (2010)
Novel double coated nanocapsules for intestinal delivery and enhanced oral bioavailability of tacrolimus, a P-gp substrate drug
Taher Nassar et al.
JOURNAL OF CONTROLLED RELEASE (2009)
Docetaxel microemulsion for enhanced oral bioavailability: Preparation and in vitro and in vivo evaluation
Yong-Mei Yin et al.
JOURNAL OF CONTROLLED RELEASE (2009)
Mechanism of inhibition of P-glycoprotein mediated efflux by vitamin E TPGS:: Influence on ATPase activity and membrane fluidity
Eva-Maria Collnot et al.
MOLECULAR PHARMACEUTICS (2007)
Oral bioavailability enhancement of acyclovir by self-microemulsifying drug delivery systems (SMEDDS)
Deepa Patel et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2007)
Enhanced oral paclitaxel absorption with vitamin E-TPGS: Effect on solubility and permeability in vitro, in situ and in vivo
MVS Varma et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2005)
A pH-sensitive microsphere system for the colon delivery of tacrolimus containing nanoparticles
A Lamprecht et al.
JOURNAL OF CONTROLLED RELEASE (2005)
Modulation of intestinal P-glycoprotein function by cremophor EL and other surfactants by an in vitro diffusion chamber method using the isolated rat intestinal membranes
Y Shono et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2004)
Enhanced oral absorption of paclitaxel in a novel self-microemulsifying drug delivery system with or without concomitant use of P-glycoprotein inhibitors
SC Yang et al.
PHARMACEUTICAL RESEARCH (2004)
Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs:: Studies with halofantrine
CJH Porter et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2004)
Establishment of new preparation method for solid dispersion formulation of tacrolimus
K Yamashita et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2003)
Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers
BD Rege et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2002)
Lipid-based formulations for intestinal lymphatic delivery
CM O'Driscoll
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2002)
Comparative studies of the enhancing effects of cyclodextrins on the solubility and oral bioavailability of tacrolimus in rats
H Arima et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2001)
Clinical utility of monitoring tacrolimus blood concentrations in liver transplant patients
R Venkataramanan et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10:: formulation development and bioavailability assessment
TR Kommuru et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2001)